Vis enkel innførsel

dc.contributor.authorStenvold, Helge
dc.contributor.authorDønnem, Tom
dc.contributor.authorAndersen, Sigve
dc.contributor.authorAl-Saad, Samer
dc.contributor.authorBusund, Lill-Tove
dc.contributor.authorBremnes, Roy M.
dc.date.accessioned2015-03-12T14:19:54Z
dc.date.available2015-03-12T14:19:54Z
dc.date.issued2014
dc.identifier.citationBMC Cancer 2014, 14:138en_US
dc.identifier.cristinIDFRIDAID 1162965
dc.identifier.doi10.1186/1471-2407-14-138
dc.identifier.issn1471-2407
dc.identifier.urihttps://hdl.handle.net/10037/7459
dc.identifier.urnURN:NBN:no-uit_munin_7036
dc.language.isoengen_US
dc.publisherBioMed Centralen_US
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762en_US
dc.subjectVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762en_US
dc.titleStage and tissue-specific prognostic impact of miR-182 in NSCLCen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel